Product Images Irbesartan

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Irbesartan NDC 65862-639 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1. Placebo-subtracted reduction in trough SeSBP; integrated analysis - irbesartan fig1

Figure 1. Placebo-subtracted reduction in trough SeSBP; integrated analysis - irbesartan fig1

This text represents dosage values for Irbesartan (a medication used to treat high blood pressure) in milligrams per day. The text is accompanied by a graph (not available) showing the reduction in SeSBP (systolic blood pressure at its lowest point, usually in the morning) achieved by Irbesartan compared to a placebo. The graph is based on an integrated analysis, possible related to clinical trials.*

Figure 1. Placebo-subtracted reduction in trough SeDBP; integrated analysis - irbesartan fig2

Figure 1. Placebo-subtracted reduction in trough SeDBP; integrated analysis - irbesartan fig2

Figure 3 - irbesartan fig3

Figure 3 - irbesartan fig3

The text provides a description of Figure 3 from IDNT study, showing Kaplan-Meier Estimates for primary endpoint events such as doubling of serum creatinine, end-stage renal disease, or all-cause mortality. The plot highlights the comparison between ibesartan and amioipine with respect to these events over a period of 57 months. It also includes the Cumulative Event Rate in percentage on the Y-axis and the Months of Follow-up on the X-axis.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 75 mg (90 Tablet Bottle) - irbesartan fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 75 mg (90 Tablet Bottle) - irbesartan fig4

This is a description for Irbesartan tablets, with each tablet containing 75mg of the active ingredient. The tablets are distributed by Aurobindo Pharma USA Inc. and come in a bottle of 90 tablets, with instructions for dosage information provided in the package insert. The tablets should be stored at room temperature, between 20°C and 25°C. The given code, "DG 6s862-637-20", may be used to identify the product.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL -75 mg Blister Carton(10 x 10 Unit-dose) - irbesartan fig5

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL -75 mg Blister Carton(10 x 10 Unit-dose) - irbesartan fig5

This is a drug package for Irbesartan Tablets, USP including 100 tablets with 75 mg each. The usual dosage instructions can be found in the package insert. It should be stored in a controlled room temperature between 20°C and 25°C. The package must be kept out of reach of children as it is not child resistant. The tablets are distributed by Aurobindo Pharma USA, Inc. and made in India. A code is provided as TS/DRUGS/22/2009.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL- 150 mg (90 Tablet Bottle) - irbesartan fig6

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL- 150 mg (90 Tablet Bottle) - irbesartan fig6

Each tablet of Irbesartan USP 150mg is distributed by Aurobindo Pharma USA, Inc. It is recommended to store the tablets at 20° to 25°C (68° to 77°F). The item is made in India and the code is TS/DRUGS/22/2009 P1422093. Dosage information can be found in the package insert.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL -150 mg Blister Carton(10 x 10 Unit-dose) - irbesartan fig7

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL -150 mg Blister Carton(10 x 10 Unit-dose) - irbesartan fig7

This is a product description for Irbesartan Tablets, USP. The usual dosage is available on the package insert. The tablets should be stored at room temperature. The package is not child-resistant, and appropriate measures should be taken to prevent children from accessing the medication. The tablets contain Irbesartan USP 150 mg and are available in a pack of 100 tablets. The packaging details, including the NDC code and the manufacturer's details, are also provided. The product was made in India.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 300 mg (90 Tablet Bottle) - irbesartan fig8

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 300 mg (90 Tablet Bottle) - irbesartan fig8

Each tablet contains 300 mg of Irbesartan USP and is distributed by Aurobindo Pharma USA, Inc. The tablets are made in India and should be stored at 20°C to 25°C. The usual dosage should be checked on the package insert, and the product is labeled with the NDC code 65862-639-90 and the code TS/DRUGS/22/2009. The tablets are Rx only and should not be printed on the dotted lines.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 300 mg (90 Tablet Bottle) - irbesartan fig9

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 300 mg (90 Tablet Bottle) - irbesartan fig9

These are Irbesartan Tablets, USP with a usual dosage, which is detailed in the package insert. They should be stored within the temperature range of 20° to 25°C (68° to 77°F) and it is suggested that if these are handed over to an outpatient, a child-resistant container should be utilized to avoid any mishap. The tablets come in 100 counts, with each tablet containing 300mg of Irbesartan USP. This product is distributed by Aurobindo Pharma USA, Inc. and was manufactured in India. No information is given regarding dotted lines or UNVARNISH ZONE, which can be considered irrelevant.*

Structure - irbesartan str

Structure - irbesartan str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.